Abstract
Background: The bladder is a highly distensible muscular sac that performs both sensory and contractile functions involved in the micturition cycle. Dysfunction of the bladder, leading to lower urinary tract symptoms (LUTS), can severely impact quality of life. Up to 87% of patients with diabetes will experience diabetic bladder dysfunction (DBD). DBD can present as either overactive bladder (OAB), underactive bladder (UAB) or both simultaneously, and is known to transition from OAB to UAB in a time-dependent manner, exacerbated by poor glycaemic control. While much research has been conducted in this area, there is little consistency between models making the literature difficult to integrate meaningfully, and the underlying mechanisms of bladder dysfunction are still not fully understood.Aim: This research project aimed to identify how Type 1 (insulin deficiency) diabetes mellitus affects the bladder, identifying changes in voiding behaviour, micturition patterns and local bladder function, via both in vivo and ex vivo experiments in a murine model of streptozotocin- (STZ) induced diabetes.
Methods: Adult (11-13 wk) Female C57BL/6J mice received daily low-dose (50-55 mg/kg) STZ intraperitoneal (i.p.) injections for 5 days followed by 10 days of monitoring and sacrificed 11 days after first injection. Voiding pattern analysis (VPA) was a semi-quantitative in vivo assessment of changes in voiding behaviour examining both total urine output and void frequency. Isolated whole bladder preparations (WBP) were an ex vivo quantitative method used to examine functional changes in the bladder including neurogenic and non-neurogenic contractile changes as well as mechanical changes in bladder compliance and capacity. Cystometry experiments were a quantitative in vivo technique examining changes in the micturition reflex and micturition cycle to contextualise the findings from the other experiments.
Results: VPA revealed a significant increase in the volume of urine produced in four hours in animals with severe hyperglycaemia (SHDb, >20 mM blood glucose at sacrifice). WBP experiments demonstrated an increase in bladder compliance and capacity in the SHDb group, whilst responses to both ATP and electric field stimulation were found to be significantly depressed in bladders from the SHDb mice. When normalised to maximum contraction (via high-potassium Krebs) however, ATP responses were no longer significantly different. WBP experiments also revealed that bladders from mice with mild hyperglycaemia (MHDb, 11.7 mM to 17.0 mM blood glucose at sacrifice) and SHDb showed a significant decrease in phasic activity frequency during filling. Cystometry experiments showed a decrease in peak voiding pressure in diabetic animals compared to controls.
Discussion: The results indicate that severe hyperglycaemia of short-term duration impacts bladder function more severely than mild hyperglycaemia. Specifically, bladder capacity and compliance increase, likely to accommodate the increased urine load. Simultaneously, there is a decreased sensitivity to filling, as well as decreased contractility during voiding. The project successfully achieved all four of the aim objectives, establishing both a diabetic model and a cystometry procedure as well as examining voiding behaviour and local bladder function. The results of this project suggest short-term severe hyperglycaemia produces reduced neurogenic responses potentially involving purinergic mechanisms, possibly emulating the UAB phenotype of DBD.
| Date of Award | 6 Jun 2024 |
|---|---|
| Original language | English |
| Supervisor | Donna Sellers (Supervisor), Catherine McDermott (Supervisor) & Russ Chess-Williams (Supervisor) |
Cite this
- Standard